Adenosine A2A Receptor Antagonist Sch58261 Improves the Cognitive Function in Alzheimer’s Disease Model Mice Through Activation of Nrf2 via an Autophagy-Dependent Pathway
Antioxidants & Redox Signaling · 2024
DOI: 10.1089/ars.2023.0455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2024. Verfasst von Yi Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, NF-E2-Related Factor 2, Autophagy, Disease Models, Animal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
- Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry and Molecular Biology, Xuzhou Medical University, Xuzhou, China.
ORCID-Profile: Ling He
Zitieren
APA
Sun, Y., Liu, C., & He, L. (2024). Adenosine A2A Receptor Antagonist Sch58261 Improves the Cognitive Function in Alzheimer’s Disease Model Mice Through Activation of Nrf2 via an Autophagy-Dependent Pathway. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2023.0455
Vancouver
Sun Y, Liu C, He L. Adenosine A2A Receptor Antagonist Sch58261 Improves the Cognitive Function in Alzheimer’s Disease Model Mice Through Activation of Nrf2 via an Autophagy-Dependent Pathway. Antioxidants & Redox Signaling. 2024. doi:10.1089/ars.2023.0455
BibTeX
@article{Sun2024,
author = {Sun, Yi and Liu, Chao and He, Ling},
title = {Adenosine A2A Receptor Antagonist Sch58261 Improves the Cognitive Function in Alzheimer’s Disease Model Mice Through Activation of Nrf2 via an Autophagy-Dependent Pathway},
journal = {Antioxidants & Redox Signaling},
year = {2024},
doi = {10.1089/ars.2023.0455}
}
EUVIMED